|1.||Görtz, P: 1 article (08/2005)|
|2.||Siebler, M: 1 article (08/2005)|
|3.||Kieseier, B C: 1 article (08/2005)|
|4.||Hartung, H P: 1 article (08/2005)|
|5.||Otto, F: 1 article (08/2005)|
|6.||Mahalakshmi, R: 1 article (03/2004)|
|7.||Sarma, S P: 1 article (03/2004)|
|8.||Sikdar, S K: 1 article (03/2004)|
|9.||Sahal, D: 1 article (03/2004)|
|10.||Chakrabarti, K S: 1 article (03/2004)|
|1.||Demyelinating Diseases (Demyelinating Disease)
12/04/2003 - "Reversible block of Na(+) channels by endogenous pentapeptide QYNAD has been reported to account for the fast relapses and remissions seen in autoimmune demyelinating disorders. "
01/28/2003 - "An endogenous pentapeptide (Gln-Tyr-Asn-Ala-Asp; QYNAD) that is present at elevated levels in human CSF from patients with demyelinating diseases has been reported to block voltage-gated sodium channels at low (10 micro M) concentrations. "
03/01/2004 - "The endogenous pentapeptide QYNAD (Gln-Tyr-Asn-Ala-Asp) is present in human cerebrospinal fluid (CSF), and its concentration is increased in demyelinating diseases. "
01/04/2002 - "The pentapeptide QYNAD, isolated from the cerebrospinal fluid from patients with multiple sclerosis (MS), blocked Na+ channels in various types of cultured cells. "
08/01/2005 - "Controversial data was published about the sodium channel-blocking effect of the endogenous pentapeptide QYNAD, which is elevated in patients with multiple sclerosis and Guillain-Barré-syndrome. "
|1.||Sodium Channels (Sodium Channel)